Status:
COMPLETED
COVID-19 Self-testing IMPROVE
Lead Sponsor:
Temple University
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims to engage community partners to implement IMPROVE intervention and promote (COVID-19) rapid testing among vulnerable Asian Americans in the Greater Philadelphia Area and New York City
Eligibility Criteria
Inclusion
- (1) self-identified as Asian from one of the subgroups: Chinese, Korean, Vietnamese, Filipino, or other South Asian Americans,
- (2) aged 18 and above,
- (3) living in the Greater Philadelphia or NYC areas,
Exclusion
- \-
Key Trial Info
Start Date :
June 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2024
Estimated Enrollment :
1271 Patients enrolled
Trial Details
Trial ID
NCT06576167
Start Date
June 15 2023
End Date
December 2 2024
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Asian Health, Lewis Katz School of Medicine, Temple University
Philadelphia, Pennsylvania, United States, 19140